Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 165,900
-7,200 (-4.16%)
At close: Jun 26, 2026
Celltrion Market Cap
Celltrion has a market cap or net worth of 36.46 trillion as of June 26, 2026. Its market cap has increased by 6.50% in one year.
Market Cap
36.46T
Enterprise Value
39.05T
Revenue
4.47T
Ranking
n/a
PE Ratio
30.24
Stock Price
165,900.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 36.46T, an increase of 35,022.67%. That is a compound annual growth rate of 38.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 36.46T | -7.94% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.17T |
| ALTEOGEN | 18.40T |
| Samsung Epis Holdings | 10.61T |
| Kolon TissueGene | 8.09T |
| SK Biopharmaceuticals | 6.49T |
| HLB Co., Ltd. | 6.34T |
| LigaChem Biosciences | 5.27T |
| Peptron | 3.89T |